Bioadaptives, Inc. (BDPT) Other Accumulated Expenses (2019 - 2026)

Bioadaptives has reported Other Accumulated Expenses for 7 years, with the latest figure at $1032.0 in Q1 2026.

• Quarterly Other Accumulated Expenses rose 1.28% year-over-year to $1032.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1032.0 (up 1.28% YoY) and the FY2025 annual result came in at $1023.0, changed 0.2% from the prior year.
• Other Accumulated Expenses rose to $1032.0 in Q1 2026 per BDPT's latest filing, from $1023.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $1032.0 in Q1 2026 and troughed at $1015.0 in Q4 2022.
• A 5-year average of $1020.4 and a median of $1019.0 in 2023 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses dropped 0.39% in 2025, then increased 1.28% in 2026.
• Over 5 years, Other Accumulated Expenses stood at $1015.0 in 2022, then advanced by 0.39% to $1019.0 in 2023, then grew by 0.2% to $1021.0 in 2024, then rose by 0.2% to $1023.0 in 2025, then grew by 0.88% to $1032.0 in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $1032.0, $1023.0, and $1019.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.